• Seattle Genetics Ends Clinical Trial Of Leukemia Drug After A Higher Rate Of Deaths

    Jun 19, 2017, 15:56 by Michael Croft
    The Seattle Times |  Seattle Genetics said it is discontinuing a Phase 3 clinical trial after data showed "a higher rate of deaths, including fatal infections" in acute myeloid leukemia patients receiving its drug than in the study's other patients.
    Full story

  • Elsevier launches solution to accelerate drug discovery through comprehensive prediction and assessment of drug-drug interactions

    Jun 19, 2017, 11:02 by Michael Croft
    NEW YORK, NY - Jun 19, 2017 - Elsevier, the information analytics company specializing in science and health, has launched the PharmaPendium DMPK (Drug Metabolism-Pharmacokinetic) solution
    Full story

  • ANTICANCER PDOX REACHES SERIES A FINANCING TARGET, APPOINTS BOARD

    Jun 16, 2017, 14:31 by Michael Croft
    SAN DIEGO, CA, UNITED STATES - Jun 1, 2017 - AntiCancer PDOX, Inc. announced today that it has reached its original Series A financing target and appointed its Board of Directors
    Full story

  • Fostering Medical Innovation A Plan for Digital Health Devices

    Jun 15, 2017, 13:22 by Michael Croft
    FDA Voice |  Scott Gottlieb introduces a new Digital Health Innovation Plan that is focused on fostering innovation at the intersection of medicine and digital health technology. This plan will include a novel, post-market approach to how we intend to regulate these digital medical devices.
    Full story

  • It’s About Time: Proactive Vs. Reactive

    Jun 15, 2017, 09:40 by Michael Croft

    Clinical Informatics News | It’s About Time | Norman Goldfarb speaks with Reg Blynn, Vice President of Client Services at QuintilesIMS, about the need for clinical sites to be more proactive in the areas of business development, patient recruitment, and quality.

    Full story

  • WIRB-Copernicus Group to Highlight New Patient Recruitment, Behavioral Assessment and Endpoint Analysis Services; Honor CISCRP and Clinical Trial Volunteers at DIA Annual Meeting

    Jun 15, 2017, 08:15 by Michael Croft
    PRINCETON, NJ - Jun 15, 2017 - WIRB-Copernicus Group® (WCG™), the world’s leading provider of solutions that measurably improve the quality and efficiency of clinical research, today announced that it will be showcasing its newest companies and technologies at the DIA Annual Meeting in Chicago, IL from June 18-22
    Full story

  • FDA Used Real-World Evidence In Heart Valve Approval

    Jun 14, 2017, 16:07 by Michael Croft
    RAPS |  The US Food and Drug Administration says it relied on real-world evidence in its decision to expand the use of Edwards Lifesciences' Sapien 3 transcatheter aortic valve replacement to valve-in-valve procedures.
    Full story

  • Controversial Trial Of Premature Infants Facing Fresh Scrutiny

    Jun 14, 2017, 16:05 by Michael Croft
    STAT |  Watchdog group argues that newly released documents show researchers continued an experiment despite learning their oxygen monitors were malfunctioning.
    Full story

  • The Future Of Strategic Partnerships Between CROs And Sponsors: A Necessary Evolution For A Better Cause?

    Jun 14, 2017, 11:10 by Michael Croft

    Clinical Informatics News Contributed Commentary | Outsourcing strategy in the drug development sector is notoriously cyclical. Companies move between using in-house teams, project-based outsourcing, functional outsourcing, and strategic partnerships in response to the changing global business climate. The requirement to adapt is not unique to trial sponsors and we should not be surprised that strategic business models need to change as well.

    Full story

  • Why Doctors Hate Electronic Records — And What Could Change That

    Jun 13, 2017, 10:43 by Michael Croft
    San Francisco Chronicle |  The health care industrial complex has spent billions of dollars and untold amounts of time trying to make medical records as flexible, invisible and unobtrusive as possible for patients and clinicians alike. The results will be well worth the expense if the records could help clinicians spend more time caring for people and less on paperwork.
    Full story

  • iSpecimen Launches Biospecimen Marketplace

    Jun 13, 2017, 09:25 by Michael Croft
    Clinical Informatics News | iSpecimen launched its marketplace today, an online shopping platform to connect life science researchers to healthcare organizations with human biospecimens.
    Full story

  • Cenduit to Launch Quantum Interactive™ Solution at DIA 2017

    Jun 12, 2017, 17:09 by Michael Croft
    RESEARCH TRIANGLE PARK, NC, UNITED STATES - Jun 12, 2017 - Celebrating its 10-year anniversary, Cenduit LLC, a joint venture between QuintilesIMS and Thermo Fisher Scientific, is showcasing its solutions and expertise as the largest interactive response technology (IRT) specialist in the world at DIA 2017, June 19-21 in Chicago
    Full story

  • Trump Names Sharpless To Lead U.S. Cancer Institute

    Jun 12, 2017, 10:07 by Michael Croft
    Science |  President Donald Trump announced his intention to appoint Norman Sharpless to be the next director of the National Cancer Institute.
    Full story

  • WIRB-Copernicus Group (WCG) Celebrates IBC Review Milestone

    Jun 12, 2017, 08:23 by Michael Croft
    PRINCETON, NJ - Jun 12, 2017 - WIRB-Copernicus IRB Group® announced today that its Institutional Biosafety Committee Services (IBC Services) group has achieved a major milestone in administering 4,000 convened IBC meetings globally
    Full story

  • Consented Cohorts Powering Observational Studies

    Jun 9, 2017, 08:35 by Michael Croft

    Clinical Informatics News | Novaseek’s Clinical Data Network for Research provides researchers with well-categorized cohorts of consented patients while allowing hospitals and physician groups to share their data and samples with researchers.

    Full story

  • Visit DDi at DIA Annual Meet on 18-22 June 2017

    Jun 9, 2017, 01:30 by Michael Croft
    CHICAGO, IL, US - Jun 9, 2017 - DDi the clinical, drug development technology & Regulatory Technology and solution provider to pharma industry is participating at DIA Annual meetMeet the DDi team to know more about their Next Gen Technology of Regulator Artificial Intelligence Tool, get a demo of "TULA" the solution to manage clinical studies, projects and vendors by combining Oversight, Performance & Risk Management & learn about the most updated version of IRT for randomization & Supply Chain Management
    Full story

  • Geneious Biologics to Power Better Biological Drug Development

    Jun 9, 2017, 01:24 by Michael Croft
    BOSTON, MA - May 23, 2017 - Geneious Biologics, an enterprise software solution for screening antibodies and related constructs using sequence data, was launched today and will change the way scientists identify antibodies for use in biological drug development
    Full story

  • Revisiting What Went Wrong In The Clinical Trial Tragedy In France

    Jun 8, 2017, 15:44 by Michael Croft
    Chemical & Engineering News |  In January 2016, one clinical trial volunteer in France died, four others were hospitalized, and two of those went on to have long-term neurological damage. Attempting to provide answers to what went wrong, a study published in Science now reports that the drug candidate responsible for the tragedy, BIA 10-2474, covalently binds several enzymes in addition to the fatty acid amide hydrolase (FAAH) it was designed to block.
    Full story

  • Polio Outbreak Is Reported In Syria, Health Officials Say

    Jun 8, 2017, 15:39 by Michael Croft
    STAT |  The new cases are vaccine-derived polioviruses and not an indication the viruses are spreading "in the wild," according to the WHO.
    Full story

  • Trump Announces He Will Keep Francis Collins As NIH Director

    Jun 7, 2017, 09:38 by Michael Croft
    STAT |  Dr. Francis Collins, a holdover from the Obama administration, will remain director of the National Institutes of Health, the White House announced.
    Full story
  • «
  • 231 (current)
  • 232
  • 233
  • 234
  • 235
  • 236
  • 237
  • 238
  • 239
  • 240
  • »